Marsh & McLennan Companies, Inc. (NYSE:MRSH – Get Free Report) CEO Dean Klisura sold 4,194 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $200.00, for a total transaction of $838,800.00. Following the completion of the sale, the chief executive officer owned 20,935 shares of the company’s stock, valued at $4,187,000. The trade was a 16.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Marsh & McLennan Companies Price Performance
NYSE:MRSH traded down $2.83 during midday trading on Monday, reaching $194.65. The stock had a trading volume of 1,867,681 shares, compared to its average volume of 2,800,981. Marsh & McLennan Companies, Inc. has a 1-year low of $156.60 and a 1-year high of $200.32. The business has a fifty day moving average price of $181.60. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a market capitalization of $92.56 billion, a PE ratio of 23.28, a P/E/G ratio of 2.67 and a beta of 0.59.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its earnings results on Thursday, October 15th. The financial services provider reported $2.03 EPS for the quarter, topping the consensus estimate of $1.96 by $0.07. The firm had revenue of $6.86 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The company’s revenue was up 8.1% on a year-over-year basis. On average, equities research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.47 earnings per share for the current fiscal year.
Marsh & McLennan Companies Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Thursday, October 1st will be given a $0.99 dividend. This represents a $3.96 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend is Thursday, October 1st. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 47.37%.
Institutional Trading of Marsh & McLennan Companies
Large investors have recently bought and sold shares of the stock. Quadrant Capital Group LLC increased its stake in shares of Marsh & McLennan Companies by 0.6% in the third quarter. Quadrant Capital Group LLC now owns 9,612 shares of the financial services provider’s stock valued at $1,701,000 after buying an additional 53 shares in the last quarter. Pinnacle Bancorp Inc. raised its holdings in shares of Marsh & McLennan Companies by 37.7% in the third quarter. Pinnacle Bancorp Inc. now owns 219 shares of the financial services provider’s stock valued at $37,000 after buying an additional 60 shares during the last quarter. Continuum Advisory LLC lifted its position in Marsh & McLennan Companies by 5.3% during the 1st quarter. Continuum Advisory LLC now owns 1,452 shares of the financial services provider’s stock worth $252,000 after buying an additional 73 shares in the last quarter. Clearstead Trust LLC lifted its position in Marsh & McLennan Companies by 12.6% during the 1st quarter. Clearstead Trust LLC now owns 668 shares of the financial services provider’s stock worth $116,000 after buying an additional 75 shares in the last quarter. Finally, Kintegral Advisory LLC grew its holdings in Marsh & McLennan Companies by 0.6% during the 3rd quarter. Kintegral Advisory LLC now owns 14,387 shares of the financial services provider’s stock worth $2,456,000 after acquiring an additional 81 shares during the last quarter. 87.99% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the company. UBS Group boosted their price objective on Marsh & McLennan Companies from $216.00 to $222.00 and gave the stock a “buy” rating in a research report on Tuesday, October 6th. Keefe, Bruyette & Woods upped their price target on Marsh & McLennan Companies from $186.00 to $201.00 and gave the stock a “market perform” rating in a report on Monday, October 19th. Morgan Stanley cut their price target on Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating for the company in a report on Tuesday, October 6th. Citigroup increased their price objective on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “neutral” rating in a research report on Friday, October 16th. Finally, Mizuho raised their price objective on shares of Marsh & McLennan Companies from $190.00 to $200.00 and gave the stock a “neutral” rating in a research note on Monday, October 19th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Marsh & McLennan Companies presently has a consensus rating of “Hold” and an average price target of $204.42.
Read Our Latest Stock Report on Marsh & McLennan Companies
About Marsh & McLennan Companies
Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.
Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.
Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
